Citations

Showing 10 of 108119 citations.

The Biological Variability of Plasma Ceramides in Healthy Subjects
Ramos, Paola , Jenkins, Sarah M. , Hartman, Stacy, Saenger, Amy K., Baumann, N, Block, Darci R , Jaffe, Allan S. , Meeusen, Jeffrey W. , Donato, Leslie J. , Hartman, Stacy J, Baumann, Nikola A, Block, Darci R , Jaffe, Allan S.

Mayo Clinic

The Journal of Applied Laboratory Medicine | January 6, 2022 | Volume: 7 | Issue: 4 | Pages: 863-870

10.1093/jalm/jfac002 | PMID 35092283 Get It

AbstractBackgroundCeramides are bioactive lipid species that mediate numerous cell-signaling events. Elevated plasma ceramides concentration constitutes a risk factor for several pathologies. Multiple studies have affirmed the plasma concentrations of 4 specific ceramides (Cer16:0, Cer18:0, Cer24:0, and Cer24:1) can predict cardiovascular disease risk. Furthermore, these ceramides can be altered by many lipid-lowering therapies. Understanding the biological variability within an individual, and within a population, will further inform the clinical use of plasma ceramides as a biomarker. In this study, we aimed to define the intra- and interbiological variability of ceramides in a healthy reference population in a weekly and monthly manner.MethodsFasting plasma from 24 healthy adults was collected daily (5 days), weekly (4 weeks), and monthly (7 months). Ceramide concentrations were measured with liquid chromatography–mass spectrometry (LC–MS). For analysis, we used random-effects regression models to estimate variance components.ResultsThe analytical variability was smaller compared to the biological variability overall. The greatest variation reported was between-subject variation for all ceramide species. The critical difference-reference change value (RCV) for within-subject variations monthly were 0.07 mcmol/L (Cer16:0), 0.04 mcmol/L (Cer18:0), 1.09 mcmol/L (Cer24:0), and 0.27 mcmol/L (Cer24:1). The index of individuality (IOI) of ceramides were 0.82 (Cer16:0), 0.96 (Cer18:0), 1.06 (Cer24:0), and 0.89 (Cer24:1). The most consistent ceramide species was Cer18:0 with the lowest within- and between-subject critical differences in weekly and monthly measurements.ConclusionsOverall, this study demonstrates that the variability of ceramide concentrations at different time points is minimal within individuals, allowing a single draw to be sufficient at least in a yearly time frame.
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation
Meeusen, Jeffrey W. , Kasozi, Ramla N. , Larson, Timothy S., Lieske, John C. , Lieske, John C

Mayo Clinic

Clinical Chemistry | January 6, 2022 | Volume: 68 | Issue: 4 | Pages: 534-539

10.1093/clinchem/hvab282 | PMID 35038721 Get It

Abstract Background The National Kidney Foundation recently endorsed the refit Chronic Kidney Disease Collaboration (CKD-EPI) equation for estimated glomerular filtration rate (eGFR) using creatinine, age and sex [2021 eGFRCr(AS)] without a coefficient for race. We evaluated the impact of adopting the 2021 eGFRCr(AS) equation or a variation of the 2009 CKD-EPI eGFR equation without race [2009 CKD-EPI eGFRCr(ASR-NB)] compared to the original CKD-EPI eGFR [2009 eGFRCr(ASR)]. Methods The studied population included patients with a clinically ordered iothalamate clearance (n = 33 889). Bias was assessed as the difference between measured and estimated GFR, P30 was defined as the percentage of estimates within 30% of measured GFR, and concordance was determined according to relevant clinical thresholds. Results Among Black patients, the median bias for 2009 eGFRCr(ASR), 2009 eGFRCr(ASR-NB), and 2021 eGFRCr(AS) was −1.32 mL min−1 (1.73 m2)−1 (95CI −2.46 to −0.26), −8.81 mL min−1 (1.73 m2)−1 (95CI −9.93 to −7.58), and −6.08 mL min−1 (1.73 m2)−1 (95CI −7.18 to −4.92), respectively. The median bias among non-Black patients was −0.15 m min−1 (1.73 m2)−1 (95CI −0.84 to −0.08) for 2021 eGFRcr(AS) compared to −3.09 mL min−1 (1.73 m2)−1 (95CI −3.17 to −3.03) for the 2009 eGFRCr(ASR). P30 and concordance were not significantly different in either racial group. The net reclassification improvement at a measured GFR <20 mL min−1 (1.73 m2)−1 was 6.4% (95CI 0.36 to 12.4) for Black patients and −5.1% (95CI −6.0 to −4.1) for non-Black patients using the 2021 eGFRCr(AS) equation. Conclusions Overall, the change in reported eGFR was minimal. However, these changes led to significant reclassification improvements at lower eGFR, which will indirectly improve equitable access to CKD resources.
Commentary: Completion Posterior Quadrant Disconnection After Failed Temporal Lobectomy: 2-Dimensional Operative Video
Singh, Rohin , Bendok, Bernard R., Zimmerman, Richard S., Singh, Rohin , Bendok, Bernard R., Zimmerman, Richard S.

Mayo Clinic

Operative Neurosurgery | January 6, 2022 | Volume: 22 | Issue: 4 | Pages: e175-e176

10.1227/ons.0000000000000088 | PMID 34989708 Get It

Pharmacological and non-pharmacological interventions for symptomatic gastroparesis
Camilleri, Michael , Andresen, Viola , Keller, Jutta, Layer, Peter , Montori, Víctor M.

Mayo Clinic

Cochrane Database of Systematic Reviews | January 6, 2022 | Volume: 2022 | Issue: 1 | Pages: No page available

10.1002/14651858.cd007116.pub2 Get It

Temporal pole blurring in temporal lobe epilepsy revealed by 3D Edge-Enhancing Gradient Echo MRI
Okromelidze, Lela , Jain, Ayushi , Gopal, Neethu , Tatum, William O. , Quiñones‐Hinojosa, Alfredo , Middlebrooks, Erik H. , Feyissa, Anteneh M. , Middlebrooks, Erik H , Gupta, Vivek , Jain, Ayushi, Grewal, Sanjeet S.

Mayo Clinic

The Neuroradiology Journal | January 6, 2022 | Volume: 37 | Issue: 3 | Pages: 386-389

10.1177/19714009211067404 | PMID 34989268 Get It

While abnormalities of the hippocampus have been well characterized in temporal lobe epilepsy, various additional temporal lobe abnormalities have also been described. One poorly understood entity, the so-called temporal pole blurring (TPB), is one of the more frequently described neocortical abnormalities in TLE and is thought to represent dysmyelination and axonal loss due to chronic electrical perturbations in early age-onset temporal lobe epilepsy. In this study, we describe the first reported cases of TPB diagnosed by a recently described MRI sequence known as 3D Edge-Enhancing Gradient Echo (3D-EDGE), which has an effective “myelin weighting” making it exquisitely sensitive to this temporal pole dysmyelination. The value of detection of TPB lies in lateralizing seizure onset, as well as predicting a lower baseline neuropsychological performance compared to temporal lobe epilepsy without TPB. Additionally, it is critical to not mistake TPB for alternative diagnoses, such as focal cortical dysplasia or neoplasm.
Incidence of Obesity at 1 and 3 Years Among Community Dwelling Adults: A Population-Based Study
DeJesus, Ramona S. , Croghan, Ivana T. , Jacobson, Debra J., Fan, Chun , St Sauver, Jennifer, DeJesus, R S , Sauver, Jennifer L. St.

Mayo Clinic

Journal of Primary Care & Community Health | January 6, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319211068632 | PMID 34986686 Get It

Objective: This study determined the incidence rates for obesity among adult patients ages 20 and older empaneled in primary care practice in Midwest United States to potentially identify an optimum timeframe for initiating intervention. Background: Primary care practice patients are likely to reflect underlying community trends in overweight and obesity; however, data on overweight and obesity in primary care patients is limited. While childhood incidence rates of obesity have been well reported, there is still a paucity of data on the incidence of obesity among adult population; literature has mainly focused on its prevalence. Methods: Medical record review of identified cohort with BMI data was conducted. Population was stratified by age and sex and overweight category was subdivided into tertiles. Results: Majority of 40 390 individuals who comprised the final population and had follow-up data, consisted of adults ages 40 to 69 years (47.5%), female (59.8%) of non-Hispanic ethnicity (95.9%) with 21 379 (52.8%) falling in weight category of overweight. Incidence of obesity was 7% at 1 year and 16% at 3 years follow-up. Highest percentages of individuals who became obese at 1 and 3 years were in age category of 40 to 69 years among men and 20 to 39 years among women. In Cox regression analysis, there was statistically significant association to developing obesity among all tertile groups in the overweight category. Age and particularly gender appeared to be modifying factors to likelihood of developing obesity. Conclusion: Study results suggest that while obesity incidence is higher among certain age groups in both genders, middle-aged women, and men in all tertiles of overweight category are at highest risk and may be the optimum population to target for weight loss interventions. Findings support the initiation of population-based interventions before onset of obesity.
Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers
McFadden, David D., Bornstein, Shari L. , Vassallo, Robert , Salonen, Bradley R. , Bhuiyan, Mohammed Nadir , Schroeder, Darrell R. , Croghan, Ivana T. , Bhuiyan, M Nadir , Vassallo, Robert , Schroeder, Darrell

Mayo Clinic

Journal of Primary Care & Community Health | January 6, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319211062672 | PMID 34986700 Get It

Objectives: The purpose of the present study was to assess and describe the severity of symptoms reported by Covid-19 positive patients who vaped (smoked e-cigarettes) when compared to those who did not vape or smoke at the time of the diagnosis of Covid-19. Methods: Patients from this study are from a well-characterized patient cohort collected at Mayo Clinic between March 1, 2020 and February 28, 2021; with confirmed COVID-19 diagnosis defined as a positive result on reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays from nasopharyngeal swab specimens. Among the 1734 eligible patients, 289 patients reported current vaping. The cohort of vapers (N = 289) was age and gender matched to 1445 covid-19 positive patients who did not vape. The data analyzed included: date of birth, gender, ethnicity, race, marital status, as well as lifestyle history such as vaping and smoking and reported covid-19 symptoms experienced. Results: A logistic regression analysis was performed separately for each symptom using generalized estimating equations (GEE) with robust variance estimates in order to account for the 1:5 age, sex, and race matched set study design. Patients who vaped and developed Covid-19 infection were more likely to have chest pain or tightness (16% vs 10%, vapers vs non vapers, P = .005), chills (25% vs 19%, vapers vs non vapers, P = .0016), myalgia (39% vs 32%, vapers vs non vapers, P = .004), headaches (49% vs 41% vapers vs non vapers, P = .026), anosmia/dysgeusia (37% vs 30%, vapers vs non vapers, P = .009), nausea/vomiting/abdominal pain (16% vs 10%, vapers vs non vapers, P = .003), diarrhea (16% vs 10%, vapers vs non vapers, P = .004), and non-severe light-headedness (16% vs 9%, vapers vs non vapers, P < .001). Conclusion: Vapers experience higher frequency of covid-19 related symptoms when compared with age and gender matched non-vapers. Further work should examine the impact vaping has on post-covid symptom experience.
VP8: Immune Response and Revascularization of Acellular Nerve Allografts Following Mesenchymal Stem Cell Seeding and Surgical Angiogenesis
Saffari, Tiam M. , Johnson, Aaron J. , Bedar, Meiwand , Johnson, Aaron J. , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | January 5, 2022 | Volume: 10 | Issue: 1S | Pages: 9-10

10.1097/01.gox.0000817712.55742.df Get It

VP7: In Vitro Comparison of Dynamic Seeding Versus Microinjection of Mesenchymal Stem Cells for Acellular Nerve Allograft
Bedar, Meiwand , Jerez, Sofía , Pulos, Nicholas , Wijnen, André J. van , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | January 5, 2022 | Volume: 10 | Issue: 1S | Pages: 9-9

10.1097/01.gox.0000817708.46386.37 Get It

VP1: Combined Local Delivery of Tacrolimus and Stem Cells in Fibrin Gel is a Viable Potential Treatment for Enhancing Peripheral Nerve Regeneration
Saffari, Tiam M. , Zuo, Kevin J. , Chan, K., Saffari, Sara , Borschel, Gregory Howard , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | January 5, 2022 | Volume: 10 | Issue: 1S | Pages: 12-13

10.1097/01.gox.0000817736.46737.16 Get It